New Drug Discovery Platform Based on Deep Phosphoproteomic Profiling
Lighting the Path to Precision Medicine.
About Kinase Insight
Kinase Insight pioneers a state-of-the-art drug discovery service platform, utilizing advanced equipment including Orbitrap Exploris 480 and Q Exactive Plus. Our mission is to deliver top-notch proteomic analysis services to a diverse range of pharmaceutical enterprises. With a specialized deep phosphoproteomic technology platform, coupled with proprietary methods and a robust bioinformatics platform, we offer comprehensive analyses covering total protein, total phosphorylation, and tyrosine phosphorylation. Our services provide efficient solutions for drug development and patient treatment, ensuring high-quality results and contributing to advancements in the field.
Efficient and Comprehensive Solutions Based on Specialized Phosphoproteomics Platform
Covers three data dimensions: total protein, total phosphorylation, and tyrosine phosphorylation.
- Neoantigen Sequencing Service
- High-Throughput Antibody Screening Service
- Oligo Mass Spectrometry Characterization
- Macromolecule Drugs (mAb,ADC,AAV) Mass Spectrometry Characterization Service